CALABASAS, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) — MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today announced that it has appointed Michael Heller to its Board of Directors.
Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party. From working with A-listers, such as Kylie Jenner, to professional athletes, such as Kyle Kuzma, Michael has a passion for connecting brands with the right talent for high impact marketing campaigns that yield big results. Amidst the COVID-19 pandemic, Michael has continued to grow the Talent Resources presence by opening offices in London, Dubai and Chicago, while continuing to expand in Boston, Los Angeles and New York.
Ryan Drexler, President and Chief Executive Officer, stated, “We are pleased to welcome Michael as a new independent director. We look forward to benefiting from his valuable marketing perspective and breadth of expertise of dramatically expanding brand awareness through many different avenues. He joins MusclePharm at an exciting time as we continue to drive our omni-channel strategy and build deeper relationships and expand our portfolio of product offerings through strategic marketing and innovation.”
“I am excited to join the board of a leading health living brand,” commented Michael Heller. “I look forward to working alongside my fellow Board members and company management to advance our offerings and enhance our marketing opportunities to ensure our leading offerings are achieving their full potential.”
The Company has made significant cost improvements in many facets of its business. As reported in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2019, Director compensation was in excess of $300,000 for each of its two non-employee Directors. This amount is anticipated to decrease by more than 50% for 2021.
About MusclePharm, Inc.
MusclePharm® is an award-winning, worldwide leading sports nutrition & lifestyle company offering branded nutritional supplements. Its portfolio of recognized properties include the MusclePharm® Sport Series, Essentials Series, and recently-launched Natural Series, as well as FitMiss™ – a product line designed specifically for female athletes. MusclePharm® products are available in more than 100 countries globally, with its Combat Protein product lineup being the company’s most popular.
Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the Company’s strategy and expansion of its product portfolio. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, risks relating to consumer spending may decline or that U.S. and global macroeconomic conditions may worsen resulting in reduced demand for the Company’s products, risks relating to changes in consumer preferences away from the Company’s offerings, risks relating to the effectiveness and efficiency of the Company’s advertising campaigns and marketing expenditures, including existing brands and the launch of new brands, which may not result in increased revenue or generate sufficient levels of brand name and program awareness, risks if the Company becomes subject to health or advertising related claims from its customers, competitors or governmental and regulatory bodies, and risks relating to increased competition from other nutrition providers.
For further details and a discussion of these risks and uncertainties, see the Company’s periodic reports, including the annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the results of any revisions to the forward-looking statements made in this press release.
John Mills, Managing Partner